Testing effectiveness (Phase 2)Study completedNCT00434434
What this trial is testing
Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma
Who this might be right for
Allergic Asthma
Genentech, Inc. 61